Laurence N. Charney is Director at TG THERAPEUTICS, INC. (TGTX). They have made 7 open-market trades across 2 companies since 2012, most recently 2026-09-10.
CIK 0001407451
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 7 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| TGTX | 168,640 | $9.1M |
| ICON | 21,434 | $22K |
| MVL | 9,000 | — |
| TGTXD | 50,000 | — |
| Total | $9.1M |
Shares reported on the most recent Form 4, priced at the 2026-09-14 close. 2 holdings could not be priced and are excluded from the total.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| TGTX | SELL | 2026-09-10 | 2026-09-14 | $54.96 | $275K | +6.8% | +0.9% | — |
| TGTX | SELL | 2024-11-11 | 2024-11-12 | $30.20 | $755K | +14.6% | +0.3% | +5.4% |
| TGTX | SELL | 2024-03-12 | 2024-03-13 | $15.97 | $351K | +0.8% | -9.0% | +3.8% |
| TGTX | SELL | 2024-01-05 | 2024-01-08 | $19.03 | $333K | -22.9% | -26.5% | -23.4% |
| TGTX | SELL | 2023-01-04 | 2023-01-06 | $11.10 | $333K | +6.8% | +66.9% | +39.8% |
| TGTX | SELL | 2017-04-04 | 2017-04-04 | $11.17 | $78K | -5.0% | -8.1% | -8.1% |
| ICON | SELL | 2012-11-28 | 2012-11-30 | $19.73 | $99K | -7.1% | -2.6% | -2.6% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.